文献速递血液净化与透析

随机试验表明血液透析或血液透析滤过期间完整肠道细菌无易位

Randomized Trial Demonstrating No Translocation of Intact Intestinal Bacteria During Hemodialysis or Hemodiafiltration.
PubMed 文献 · Kidney Int Rep · 2024-10-10

结果显示所有样本均无微生物DNA,各模式急性期反应标志物变化相似,校正血液浓缩后多数下降,提示高容量血液透析滤过的生存优势不太可能由肠道完整性保护解释。

要点

  • 所有透析模式和样本中均未检测到循环微生物DNA。
  • 各模式急性期反应标志物变化相似,校正血液浓缩后多数下降。
  • 高容量血液透析滤过的生存优势不太可能由肠道完整性保护解释。

核心结论

  • 未检测到循环微生物DNA,且各模式均未观察到细菌易位或急性期反应,高容量血液透析滤过的生存优势不太可能由肠道完整性保护解释。

研究设计与样本

  • 透析前后通过16S至23S间隔区谱定量检测血中微生物DNA,并评估透析中急性期反应。

主要发现

  • 所有样本中微生物DNA均缺失。
  • IL-6R、sCD14和VCAM-1在所有模式中均等升高,中位升高分别为12.5%、14.0%、14.8%(P < 0.05)。
  • hs-CRP仅在低温血液透析和高容量血液透析滤过中升高,中位升高12.6%(P < 0.05)。
  • 校正血液浓缩后,sCD14和VCAM-1在所有模式中中位下降分别为-11.3%和-14.4%,IL-6R在低温血液透析、低容量和高容量血液透析滤过中中位下降-13.4%(P < 0.05)。
  • 校正血液浓缩后,hs-CRP仅在低温血液透析中下降-13.5%(P = 0.004)。

临床怎么用

  • 本研究提示高容量血液透析滤过改善生存的机制可能并非通过减少细菌易位或急性期反应,临床不应以此作为选择该模式的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The low incidence of intradialytic hypotension (IDH) in high-volume (HV) hemodiafiltration (HDF) may help in maintaining gut perfusion during treatment. Preservation of gut endothelial integrity would limit or prevent bacterial translocation and subsequent systemic inflammation, which may contribute to the low mortality rate in HV-HDF. METHODS: Forty patients were cross-over randomized to standard (hemodialysis [HD]) (S-HD), cool HD (C-HD), and HDF (low-volume [LV] and HV, convection volume (CV) of 15 L and ≥ 23 L per session, respectively), each for 2 weeks. Quantitative assessment of microbial DNA (mDNA) in blood was performed before and after dialysis by 16S to 23S interspace profiling after DNA isolation. The intradialytic acute phase response (APR) was evaluated by high-sensitivity C-reactive protein (hs-CRP), interleukin-6 receptor (IL-6R), soluble CD14 (sCD14), and vascular-cell-adhesion molecule-1 (VCAM-1). Differences between modalities were primary objectives. RESULTS: mDNA was absent from all samples. IL-6R, sCD14, and VCAM-1 increased equally in all modalities (median increase: 12.5%, 14.0%, 14.8%, respectively; P < 0.05). hs-CRP increased only in C-HD and HV-HDF (median increase: 12.6%, P < 0.05). After correction for hemoconcentration, most APR markers decreased (median: sCD14, -11.3% and VCAM-1, -14.4% in all modalities; IL-6R, -13.4% in C-HD, LV-HDF, and HV-HDF; P < 0.05). hs-CRP only decreased in C-HD (-13.5%, P = 0.004). CONCLUSION: From this study, we conclude as follows: (i) circulating mDNA could not be demonstrated; (ii) in the crude analysis, a similar APR was noted in all modalities, individual markers remained stable or declined after correction for hemoconcentration; and (iii) because neither bacterial translocation nor an APR was observed in either modality, it is highly unlikely that the superior survival of HV-HDF is explained by a superior preservation of gut integrity.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Rootjes PA, Grooteman MPC, Budding AE, et al. Randomized Trial Demonstrating No Translocation of Intact Intestinal Bacteria During Hemodialysis or Hemodiafiltration. Kidney Int Rep. 2024. PMID: 39810793. doi:10.1016/j.ekir.2024.09.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。